IOVA PEER ANALYSIS

Iovance Biotherapeutics Inc — metric-by-metric comparison with peers and the industry median

IOVAIovance Biotherapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

IOVAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	IOVA	MSB	TLX	CSL	RTALB	Ind. Median
P/E	—	—	—	30.02	4.89●	17.81
P/B	2.43	—	6.56	2.24	0.61●	3.49
EV/EBITDA	—	—	123.31	10.37●	74.61	14.92
P/S	6.14	31.91	3.34	2.67●	6.67	10.89

Financial Health
Metric	IOVA	MSB	TLX	CSL	RTALB	Ind. Median
Current Ratio	3.60●	—	1.43	2.57	1.21	5.90
Debt/Equity	6.6%	—	112.3%	67.4%	1.2%●	10.9%
NetDebt/EBITDA	0.83●	—	13.13	2.22	0.90	1.15

Profitability
Metric	IOVA	MSB	TLX	CSL	RTALB	Ind. Median
Net Margin	-123.9%	-115.3%	-0.9%	9.2%	136.3%●	-125.7%
ROE	-47.5%	-11.3%	-1.8%	7.7%	15.1%●	-47.5%
ROA	-37.4%	-8.6%	-0.7%	3.8%	13.1%●	-35.8%
EBITDA Margin	-112.5%	-76.6%	3.0%	32.8%●	9.0%	-105.8%

Growth + Dividend
Metric	IOVA	MSB	TLX	CSL	RTALB	Ind. Median
Rev. Growth	34.3%	410.4%●	56.3%	4.8%	24.0%	5.1%
NI Growth	—	—	—	-39.4%	134.0%●	12.1%
Div. Yield	—	0.0%	—	2.5%●	0.0%	0.2%
Payout	—	0.0%	—	103.1%	0.0%	0.0%

Valuation
Metric	IOVA	ANAB	PGEN	SNDX	TYRA	INVA	Ind. Median
P/E	—	—	—	—	—	3.67	17.81
P/B	2.43	140.25	86.62	45.95	4.92	1.38●	3.49
EV/EBITDA	—	30.41	—	—	—	2.45●	14.92
P/S	6.14	7.69	55.47	8.81	—	4.37●	10.89

Financial Health
Metric	IOVA	ANAB	PGEN	SNDX	TYRA	INVA	Ind. Median
Current Ratio	3.60	7.58	4.82	5.47	20.49	21.13●	5.90
Debt/Equity	6.6%	2,175.8%	485.5%	829.8%	1.5%●	24.7%	10.9%
NetDebt/EBITDA	0.83	-0.16	-0.22	0.04	2.89	-0.44●	1.15

Profitability
Metric	IOVA	ANAB	PGEN	SNDX	TYRA	INVA	Ind. Median
Net Margin	-123.9%	-11.5%	-647.0%	-112.0%	—	118.9%●	-125.7%
ROE	-47.5%	-114.6%	—	-189.5%	-36.9%	50.7%●	-47.5%
ROA	-37.4%	-7.1%	-152.9%	-43.7%	-34.7%	32.6%●	-35.8%
EBITDA Margin	-112.5%	25.2%	-617.8%	-74.8%	—	150.9%●	-105.8%

Growth + Dividend
Metric	IOVA	ANAB	PGEN	SNDX	TYRA	INVA	Ind. Median
Rev. Growth	34.3%	107.7%	652.1%●	396.7%	-100.0%	13.6%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on IOVA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.